A new drug for patients who have a hard time controlling their asthma could be nearing an FDA review. Tarrytown, NY-based Regeneron Pharmaceuticals (NASDAQ: REGN) and partner Sanofi this morning are touting results this morning from a 1,902-patient Phase 3 study called Liberty Asthma Quest. In it, their injectable antibody drug dupilumab (Dupixent), already approved […]
NYS Entity Status
NYS Filing Date
JULY 28, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - KNOWLEDGE STRATEGY SOLUTIONS, LLC
Around the Web
- Regeneron Touts Success in Big Asthma Drug Study, Plans FDA Filing
By Ben Fidler - Monday Sep 11, 2017
- Bannon Ready for #War With a Long List of Targets
By JIM RUTENBERG - Sunday Aug 20, 2017
Calling himself “Bannon the Barbarian,” the president’s former strategy adviser says he’s ready to “crush” his foes inside and outside the White House.
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.
- The Top 10 Moments of New York Fashion Week
By THE NEW YORK TIMES - Friday Sep 15, 2017
Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.
- SpotX Launches Advanced Solutions Group
Monday Jul 10, 2017
Video ad-serving platform SpotX announced the creation of the company's global consulting arm, Advanced Solutions Group, set to help advertisers and media owners develop new strategies, with a focuson emerging, high-value technologies like OTT (over-the-top) TV ad serving.